Whole-Genome Sequencing Trials Suggest Time Has Come to Bring Personalized Medicine to Cancer Field

Pathologists will be interested to learn how French researchers used whole genome sequencing of breast cancer tumors to help with diagnosis and decisions about therapy

Pathologists take note! Human whole-genome sequencing of tumors was the source of information for making treatment decisions in a recently-published study. For the first time, researchers conducted a large trial involving testing the entire genome of individual breast cancers with the aim of personalized treatment.

This is the latest example of how rapid evolution of whole-genome sequencing technology now allows researchers to evaluate clinical applications for human whole-genome sequencing. The results are promising.

The research study was conducted at the French National Institute of Health and Medical Research (INSERM). The researchers released their findings at the ESMO (European Society for Medical Oncology) 2012 Congress, held recently in Vienna, according to an ESMO press release. (more…)